cancer-associated fibroblast; hypoxia; pancreatic cancer
Abstract :
[en] Despite extensive research, the 5-year survival rate of pancreatic cancer (PDAC) patients remains at only 9%. Patients often show poor treatment response, due partly to a highly complex tumor microenvironment (TME). Cancer-associated fibroblast (CAF) heterogeneity is characteristic of the pancreatic TME, where several CAF subpopulations have been identified, such as myofibroblastic CAFs (myCAFs), inflammatory CAFs (iCAFs), and antigen presenting CAFs (apCAFs). In PDAC, cancer cells continuously adapt their metabolism (metabolic switch) to environmental changes in pH, oxygenation, and nutrient availability. Recent advances show that these environmental alterations are all heavily driven by stromal CAFs. CAFs and cancer cells exchange cytokines and metabolites, engaging in a tight bidirectional crosstalk, which promotes tumor aggressiveness and allows constant adaptation to external stress, such as chemotherapy. In this review, we summarize CAF diversity and CAF-mediated metabolic rewiring, in a PDAC-specific context. First, we recapitulate the most recently identified CAF subtypes, focusing on the cell of origin, activation mechanism, species-dependent markers, and functions. Next, we describe in detail the metabolic crosstalk between CAFs and tumor cells. Additionally, we elucidate how CAF-driven paracrine signaling, desmoplasia, and acidosis orchestrate cancer cell metabolism. Finally, we highlight how the CAF/cancer cell crosstalk could pave the way for new therapeutic strategies.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Peiffer, Raphaël; Metastasis Research Laboratory, GIGA-Cancer, University of Liège, 4000 Liège, Belgium
Boumahd, Yasmine; Metastasis Research Laboratory, GIGA-Cancer, University of Liège, 4000 Liège, Belgium
Gullo, Charlotte; Metastasis Research Laboratory, GIGA-Cancer, University of Liège, 4000 Liège, BelgiumMetastasis Research Laboratory, GIGA-Cancer, University of Liège, 4000 Liège, Belgium
Crake, Rebekah; Laboratory of Tumor and Development Biology, GIGA-Cancer, University of Liège, 4000 Liège, Belgium
LETELLIER, Elisabeth ; University of Luxembourg > Faculty of Science, Technology and Medicine (FSTM) > Department of Life Sciences and Medicine (DLSM)
Bellahcène, Akeila; Metastasis Research Laboratory, GIGA-Cancer, University of Liège, 4000 Liège, Belgium
Peulen, Olivier; Metastasis Research Laboratory, GIGA-Cancer, University of Liège, 4000 Liège, Belgium
External co-authors :
yes
Language :
English
Title :
Cancer-Associated Fibroblast Diversity Shapes Tumor Metabolism in Pancreatic CancerCancer-Associated Fibroblast Diversity Shapes Tumor Metabolism in Pancreatic Cancer
Publication date :
2023
Journal title :
Cancers
eISSN :
2072-6694
Publisher :
Multidisciplinary Digital Publishing Institute (MDPI), Basel, Switzerland
Orth M. Metzger P. Gerum S. Mayerle J. Schneider G. Belka C. Schnurr M. Lauber K. Pancreatic Ductal Adenocarcinoma: Biological Hallmarks, Current Status, and Future Perspectives of Combined Modality Treatment Approaches Radiat. Oncol. 2019 14 141 10.1186/s13014-019-1345-6 31395068
Feig C. Gopinathan A. Neesse A. Chan D.S. Cook N. Tuveson D.A. The Pancreas Cancer Microenvironment Clin. Cancer Res. 2012 18 4266 4276 10.1158/1078-0432.CCR-11-3114 22896693
Dougan S.K. The Pancreatic Cancer Microenvironment Cancer J. 2017 23 321 325 10.1097/PPO.0000000000000288
Belhabib I. Zaghdoudi S. Lac C. Bousquet C. Jean C. Extracellular Matrices and Cancer-Associated Fibroblasts: Targets for Cancer Diagnosis and Therapy? Cancers 2021 13 3466 10.3390/cancers13143466
Walter K. Omura N. Hong S.-M. Griffith M. Goggins M. Pancreatic Cancer Associated Fibroblasts Display Normal Allelotypes Cancer Biol. Ther. 2008 7 882 888 10.4161/cbt.7.6.5869
Collins M.A. Bednar F. Zhang Y. Brisset J.-C. Galbán S. Galbán C.J. Rakshit S. Flannagan K.S. Adsay N.V. di Magliano M.P. Oncogenic Kras Is Required for Both the Initiation and Maintenance of Pancreatic Cancer in Mice J. Clin. Investig. 2012 122 639 653 10.1172/JCI59227
Apte M. Haber P. Applegate T. Norton I. McCaughan G. Korsten M. Pirola R. Wilson J. Periacinar Stellate Shaped Cells in Rat Pancreas: Identification, Isolation, and Culture Gut 1998 43 128 133 10.1136/gut.43.1.128
Bachem M.G. Schünemann M. Ramadani M. Siech M. Beger H. Buck A. Zhou S. Schmid-Kotsas A. Adler G. Pancreatic Carcinoma Cells Induce Fibrosis by Stimulating Proliferation and Matrix Synthesis of Stellate Cells Gastroenterology 2005 128 907 921 10.1053/j.gastro.2004.12.036
Helms E.J. Berry M.W. Chaw R.C. DuFort C.C. Sun D. Onate M.K. Oon C. Bhattacharyya S. Sanford-Crane H. Horton W. et al. Mesenchymal Lineage Heterogeneity Underlies Nonredundant Functions of Pancreatic Cancer–Associated Fibroblasts Cancer Discov. 2022 12 484 501 10.1158/2159-8290.CD-21-0601
Arina A. Idel C. Hyjek E.M. Alegre M.-L. Wang Y. Bindokas V.P. Weichselbaum R.R. Schreiber H. Tumor-Associated Fibroblasts Predominantly Come from Local and Not Circulating Precursors Proc. Natl. Acad. Sci. USA 2016 113 7551 7556 10.1073/pnas.1600363113
Miyazaki Y. Oda T. Inagaki Y. Kushige H. Saito Y. Mori N. Takayama Y. Kumagai Y. Mitsuyama T. Kida Y.S. Adipose-Derived Mesenchymal Stem Cells Differentiate into Heterogeneous Cancer-Associated Fibroblasts in a Stroma-Rich Xenograft Model Sci. Rep. 2021 11 4690 10.1038/s41598-021-84058-3 33633222
Sahai E. Astsaturov I. Cukierman E. DeNardo D.G. Egeblad M. Evans R.M. Fearon D. Greten F.R. Hingorani S.R. Hunter T. et al. A Framework for Advancing Our Understanding of Cancer-Associated Fibroblasts Nat. Rev. Cancer 2020 20 174 186 10.1038/s41568-019-0238-1 31980749
Garcia P.E. Adoumie M. Kim E.C. Zhang Y. Scales M.K. El-Tawil Y.S. Shaikh A.Z. Wen H.-J. Bednar F. Allen B.L. et al. Differential Contribution of Pancreatic Fibroblast Subsets to the Pancreatic Cancer Stroma Cell Mol. Gastroenterol. Hepatol. 2020 10 581 599 10.1016/j.jcmgh.2020.05.004 32454112
Fendrich V. Oh E. Bang S. Karikari C. Ottenhof N. Bisht S. Lauth M. Brossart P. Katsanis N. Maitra A. et al. Ectopic Overexpression of Sonic Hedgehog (Shh) Induces Stromal Expansion and Metaplasia in the Adult Murine Pancreas Neoplasia 2011 13 923 930 10.1593/neo.11088
Elyada E. Bolisetty M. Laise P. Flynn W.F. Courtois E.T. Burkhart R.A. Teinor J.A. Belleau P. Biffi G. Lucito M.S. et al. Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts Cancer Discov. 2019 9 1102 1123 10.1158/2159-8290.CD-19-0094
Wang Y. Liang Y. Xu H. Zhang X. Mao T. Cui J. Yao J. Wang Y. Jiao F. Xiao X. et al. Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Identifies a Novel Fibroblast Subtype Associated with Poor Prognosis but Better Immunotherapy Response Cell Discov. 2021 7 36 10.1038/s41421-021-00271-4
Delitto D. Pham K. Vlada A.C. Sarosi G.A. Thomas R.M. Behrns K.E. Liu C. Hughes S.J. Wallet S.M. Trevino J.G. Patient-Derived Xenograft Models for Pancreatic Adenocarcinoma Demonstrate Retention of Tumor Morphology through Incorporation of Murine Stromal Elements Am. J. Pathol. 2015 185 1297 1303 10.1016/j.ajpath.2015.01.016
Desmoulière A. Geinoz A. Gabbiani F. Gabbiani G. Transforming Growth Factor-Beta 1 Induces Alpha-Smooth Muscle Actin Expression in Granulation Tissue Myofibroblasts and in Quiescent and Growing Cultured Fibroblasts J. Cell Biol. 1993 122 103 111 10.1083/jcb.122.1.103
Hinz B. Formation and Function of the Myofibroblast during Tissue Repair J. Investig. Dermatol. 2007 127 526 537 10.1038/sj.jid.5700613
Tomasek J.J. Gabbiani G. Hinz B. Chaponnier C. Brown R.A. Myofibroblasts and Mechano-Regulation of Connective Tissue Remodelling Nat. Rev. Mol. Cell Biol. 2002 3 349 363 10.1038/nrm809
Yang X. Chen B. Liu T. Chen X. Reversal of Myofibroblast Differentiation: A Review Eur. J. Pharmacol. 2014 734 83 90 10.1016/j.ejphar.2014.04.007 24742377
Wynn T. Cellular and Molecular Mechanisms of Fibrosis J. Pathol. 2008 214 199 210 10.1002/path.2277 18161745
Wang Y. Fan P.-S. Kahaleh B. Association between Enhanced Type I Collagen Expression and Epigenetic Repression of the FLI1 Gene in Scleroderma Fibroblasts Arthritis Rheum. 2006 54 2271 2279 10.1002/art.21948 16802366
Kalluri R. The Biology and Function of Fibroblasts in Cancer Nat. Rev. Cancer 2016 16 582 598 10.1038/nrc.2016.73 27550820
Dominguez C.X. Müller S. Keerthivasan S. Koeppen H. Hung J. Gierke S. Breart B. Foreman O. Bainbridge T.W. Castiglioni A. et al. Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15+ Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy Cancer Discov. 2020 10 232 253 10.1158/2159-8290.CD-19-0644 31699795
Nurmik M. Ullmann P. Rodriguez F. Haan S. Letellier E. In Search of Definitions: Cancer-Associated Fibroblasts and Their Markers Int. J. Cancer 2020 146 895 905 10.1002/ijc.32193
Biffi G. Tuveson D.A. Diversity and Biology of Cancer-Associated Fibroblasts Physiol. Rev. 2021 101 147 176 10.1152/physrev.00048.2019
Berdiel-Acer M. Sanz-Pamplona R. Calon A. Cuadras D. Berenguer A. Sanjuan X. Paules M.J. Salazar R. Moreno V. Batlle E. et al. Differences between CAFs and Their Paired NCF from Adjacent Colonic Mucosa Reveal Functional Heterogeneity of CAFs, Providing Prognostic Information Mol. Oncol. 2014 8 1290 1305 10.1016/j.molonc.2014.04.006
Öhlund D. Handly-Santana A. Biffi G. Elyada E. Almeida A.S. Ponz-Sarvise M. Corbo V. Oni T.E. Hearn S.A. Lee E.J. et al. Distinct Populations of Inflammatory Fibroblasts and Myofibroblasts in Pancreatic Cancer J. Exp. Med. 2017 214 579 596 10.1084/jem.20162024
Hosein A.N. Huang H. Wang Z. Parmar K. Du W. Huang J. Maitra A. Olson E. Verma U. Brekken R.A. Cellular Heterogeneity during Mouse Pancreatic Ductal Adenocarcinoma Progression at Single-Cell Resolution JCI Insight 2019 4 e129212 10.1172/jci.insight.129212
Peng J. Sun B.-F. Chen C.-Y. Zhou J.-Y. Chen Y.-S. Chen H. Liu L. Huang D. Jiang J. Cui G.-S. et al. Single-Cell RNA-Seq Highlights Intra-Tumoral Heterogeneity and Malignant Progression in Pancreatic Ductal Adenocarcinoma Cell Res. 2019 29 725 738 10.1038/s41422-019-0195-y 31273297
Krishnamurty A.T. Shyer J.A. Thai M. Gandham V. Buechler M.B. Yang Y.A. Pradhan R.N. Wang A.W. Sanchez P.L. Qu Y. et al. LRRC15+ Myofibroblasts Dictate the Stromal Setpoint to Suppress Tumour Immunity Nature 2022 611 148 154 10.1038/s41586-022-05272-1 36171287
Jaster R. Molecular Regulation of Pancreatic Stellate Cell Function Mol. Cancer 2004 3 26 10.1186/1476-4598-3-26 15469605
Lieubeau B. Garrigue L. Barbieux I. Meflah K. Gregoire M. The Role of Transforming Growth Factor Beta 1 in the Fibroblastic Reaction Associated with Rat Colorectal Tumor Development Cancer Res. 1994 54 6526 6532
Löhr M. Schmidt C. Ringel J. Kluth M. Müller P. Nizze H. Jesnowski R. Transforming Growth Factor-Beta1 Induces Desmoplasia in an Experimental Model of Human Pancreatic Carcinoma Cancer Res. 2001 61 550 555
Pickup M. Novitskiy S. Moses H.L. The Roles of TGFβ in the Tumour Microenvironment Nat. Rev. Cancer 2013 13 788 799 10.1038/nrc3603
Shi Y. Massagué J. Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus Cell 2003 113 685 700 10.1016/S0092-8674(03)00432-X
Dennler S. Itoh S. Vivien D. ten Dijke P. Huet S. Gauthier J.-M. Direct Binding of Smad3 and Smad4 to Critical TGFβ-Inducible Elements in the Promoter of Human Plasminogen Activator Inhibitor-Type 1 Gene EMBO J. 1998 17 3091 3100 10.1093/emboj/17.11.3091
Massagué J. Gomis R.R. The Logic of TGFβ Signaling FEBS Lett. 2006 580 2811 2820 10.1016/j.febslet.2006.04.033
Carthy J.M. Sundqvist A. Heldin A. van Dam H. Kletsas D. Heldin C.-H. Moustakas A. Tamoxifen Inhibits TGF-β-Mediated Activation of Myofibroblasts by Blocking Non-Smad Signaling Through ERK1/2 J. Cell Physiol. 2015 230 3084 3092 10.1002/jcp.25049
Thayer S.P. di Magliano M.P. Heiser P.W. Nielsen C.M. Roberts D.J. Lauwers G.Y. Qi Y.P. Gysin S. Fernández-del Castillo C. Yajnik V. et al. Hedgehog Is an Early and Late Mediator of Pancreatic Cancer Tumorigenesis Nature 2003 425 851 856 10.1038/nature02009 14520413
Ingham P.W. McMahon A.P. Hedgehog Signaling in Animal Development: Paradigms and Principles Genes Dev. 2001 15 3059 3087 10.1101/gad.938601
Tian H. Callahan C.A. DuPree K.J. Darbonne W.C. Ahn C.P. Scales S.J. de Sauvage F.J. Hedgehog Signaling Is Restricted to the Stromal Compartment during Pancreatic Carcinogenesis Proc. Natl. Acad. Sci. USA 2009 106 4254 4259 10.1073/pnas.0813203106 19246386
Bailey J.M. Swanson B.J. Hamada T. Eggers J.P. Singh P.K. Caffery T. Ouellette M.M. Hollingsworth M.A. Sonic Hedgehog Promotes Desmoplasia in Pancreatic Cancer Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 2008 14 5995 6004 10.1158/1078-0432.CCR-08-0291 18829478
Steele N.G. Biffi G. Kemp S.B. Zhang Y. Drouillard D. Syu L. Hao Y. Oni T.E. Brosnan E. Elyada E. et al. Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 2021 27 2023 2037 10.1158/1078-0432.CCR-20-3715
Malik R. Luong T. Cao X. Han B. Shah N. Franco-Barraza J. Han L. Shenoy V.B. Lelkes P.I. Cukierman E. Rigidity Controls Human Desmoplastic Matrix Anisotropy to Enable Pancreatic Cancer Cell Spread via Extracellular Signal-Regulated Kinase 2 Matrix Biol. 2019 81 50 69 10.1016/j.matbio.2018.11.001
Bernard V. Semaan A. Huang J. Lucas F.A.S. Mulu F.C. Stephens B.M. Guerrero P.A. Huang Y. Zhao J. Kamyabi N. et al. Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression Clin. Cancer Res. 2019 25 2194 2205 10.1158/1078-0432.CCR-18-1955 30385653
Somerville T.D. Biffi G. Daßler-Plenker J. Hur S.K. He X.-Y. Vance K.E. Miyabayashi K. Xu Y. Maia-Silva D. Klingbeil O. et al. Squamous Trans-Differentiation of Pancreatic Cancer Cells Promotes Stromal Inflammation eLife 2020 9 e53381 10.7554/eLife.53381
Vianello F. Papeta N. Chen T. Kraft P. White N. Hart W.K. Kircher M.F. Swart E. Rhee S. Palù G. et al. Murine B16 Melanomas Expressing High Levels of the Chemokine Stromal-Derived Factor-1/CXCL12 Induce Tumor-Specific T Cell Chemorepulsion and Escape from Immune Control J. Immunol. Baltim. Md 1950 2006 176 2902 2914 10.4049/jimmunol.176.5.2902
Poznansky M.C. Olszak I.T. Foxall R. Evans R.H. Luster A.D. Scadden D.T. Active Movement of T Cells Away from a Chemokine Nat. Med. 2000 6 543 548 10.1038/75022
Zhou W. Guo S. Liu M. Burow M.E. Wang G. Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy Curr. Med. Chem. 2019 26 3026 3041 10.2174/0929867324666170830111531 28875842
Li X. Ma Q. Xu Q. Liu H. Lei J. Duan W. Bhat K. Wang F. Wu E. Wang Z. SDF-1/CXCR4 Signaling Induces Pancreatic Cancer Cell Invasion and Epithelial-Mesenchymal Transition in Vitro through Non-Canonical Activation of Hedgehog Pathway Cancer Lett. 2012 322 169 176 10.1016/j.canlet.2012.02.035 22450749
Huang L. Hu B. Ni J. Wu J. Jiang W. Chen C. Yang L. Zeng Y. Wan R. Hu G. et al. Transcriptional Repression of SOCS3 Mediated by IL-6/STAT3 Signaling via DNMT1 Promotes Pancreatic Cancer Growth and Metastasis J. Exp. Clin. Cancer Res. CR 2016 35 27 10.1186/s13046-016-0301-7 26847351
Wu Y.S. Chung I. Wong W.F. Masamune A. Sim M.S. Looi C.Y. Paracrine IL-6 Signaling Mediates the Effects of Pancreatic Stellate Cells on Epithelial-Mesenchymal Transition via Stat3/Nrf2 Pathway in Pancreatic Cancer Cells Biochim. Biophys. Acta BBA—Gen. Subj. 2017 1861 296 306 10.1016/j.bbagen.2016.10.006
Grünwald B.T. Devisme A. Andrieux G. Vyas F. Aliar K. McCloskey C.W. Macklin A. Jang G.H. Denroche R. Romero J.M. et al. Spatially Confined Sub-Tumor Microenvironments in Pancreatic Cancer Cell 2021 184 5577 5592.e18 10.1016/j.cell.2021.09.022
Biffi G. Oni T.E. Spielman B. Hao Y. Elyada E. Park Y. Preall J. Tuveson D.A. IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma Cancer Discov. 2019 9 282 301 10.1158/2159-8290.CD-18-0710
Taga T. Kishimoto T. Gp130 and the Interleukin-6 Family of Cytokines Annu. Rev. Immunol. 1997 15 797 819 10.1146/annurev.immunol.15.1.797
Dubois C.M. Ruscetti F.W. Palaszynski E.W. Falk L.A. Oppenheim J.J. Keller J.R. Transforming Growth Factor Beta Is a Potent Inhibitor of Interleukin 1 (IL-1) Receptor Expression: Proposed Mechanism of Inhibition of IL-1 Action J. Exp. Med. 1990 172 737 744 10.1084/jem.172.3.737
Sherman M.H. Yu R.T. Engle D.D. Ding N. Atkins A.R. Tiriac H. Collisson E.A. Connor F. Van Dyke T. Kozlov S. et al. Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy Cell 2014 159 80 93 10.1016/j.cell.2014.08.007
Tjomsland V. Spångeus A. Välilä J. Sandström P. Borch K. Druid H. Falkmer S. Falkmer U. Messmer D. Larsson M. Interleukin 1α Sustains the Expression of Inflammatory Factors in Human Pancreatic Cancer Microenvironment by Targeting Cancer-Associated Fibroblasts Neoplasia 2011 13 664-IN3 10.1593/neo.11332
Das S. Shapiro B. Vucic E.A. Vogt S. Bar-Sagi D. Tumor Cell–Derived IL1β Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer Cancer Res. 2020 80 1088 1101 10.1158/0008-5472.CAN-19-2080 31915130
Maeda K. Enomoto A. Hara A. Asai N. Kobayashi T. Horinouchi A. Maruyama S. Ishikawa Y. Nishiyama T. Kiyoi H. et al. Identification of Meflin as a Potential Marker for Mesenchymal Stromal Cells Sci. Rep. 2016 6 22288 10.1038/srep22288
Mizutani Y. Kobayashi H. Iida T. Asai N. Masamune A. Hara A. Esaki N. Ushida K. Mii S. Shiraki Y. et al. Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis Cancer Res. 2019 79 5367 5381 10.1158/0008-5472.CAN-19-0454 31439548
Collisson E.A. Sadanandam A. Olson P. Gibb W.J. Truitt M. Gu S. Cooc J. Weinkle J. Kim G.E. Jakkula L. et al. Subtypes of Pancreatic Ductal Adenocarcinoma and Their Differing Responses to Therapy Nat. Med. 2011 17 500 503 10.1038/nm.2344 21460848
Bailey P. Chang D.K. Nones K. Johns A.L. Patch A.-M. Gingras M.-C. Miller D.K. Christ A.N. Bruxner T.J.C. Quinn M.C. et al. Genomic Analyses Identify Molecular Subtypes of Pancreatic Cancer Nature 2016 531 47 52 10.1038/nature16965 26909576
Moffitt R.A. Marayati R. Flate E.L. Volmar K.E. Loeza S.G.H. Hoadley K.A. Rashid N.U. Williams L.A. Eaton S.C. Chung A.H. et al. Virtual Microdissection Identifies Distinct Tumor- and Stroma-Specific Subtypes of Pancreatic Ductal Adenocarcinoma Nat. Genet. 2015 47 1168 1178 10.1038/ng.3398
Birnbaum D.J. Begg S.K.S. Finetti P. Vanderburg C. Kulkarni A.S. Neyaz A. Hank T. Tai E. Deshpande V. Bertucci F. et al. Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma Clin. Cancer Res. 2021 27 2314 2325 10.1158/1078-0432.CCR-20-1039
Martínez-Reyes I. Chandel N.S. Cancer Metabolism: Looking Forward Nat. Rev. Cancer 2021 21 669 680 10.1038/s41568-021-00378-6
Warburg O. Über Den Stoffwechsel Der Carcinomzelle Naturwissenschaften 1924 12 1131 1137 10.1007/BF01504608
Vander Heiden M.G. Cantley L.C. Thompson C.B. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation Science 2009 324 1029 1033 10.1126/science.1160809
DeBerardinis R.J. Chandel N.S. We Need to Talk about the Warburg Effect Nat. Metab. 2020 2 127 129 10.1038/s42255-020-0172-2
Viale A. Pettazzoni P. Lyssiotis C.A. Ying H. Sánchez N. Marchesini M. Carugo A. Green T. Seth S. Giuliani V. et al. Oncogene Ablation-Resistant Pancreatic Cancer Cells Depend on Mitochondrial Function Nature 2014 514 628 632 10.1038/nature13611 25119024
Rademaker G. Hennequière V. Brohée L. Nokin M.-J. Lovinfosse P. Durieux F. Gofflot S. Bellier J. Costanza B. Herfs M. et al. Myoferlin Controls Mitochondrial Structure and Activity in Pancreatic Ductal Adenocarcinoma, and Affects Tumor Aggressiveness Oncogene 2018 37 4398 4412 10.1038/s41388-018-0287-z 29720728
Martínez-Reyes I. Robles Cardona L. Kong H. Vasan K. McElroy G.S. Werner M. Kihshen H. Reczek C.R. Weinberg S.E. Gao P. et al. Mitochondrial Ubiquinol Oxidation Is Necessary for Tumor Growth Nature 2020 585 288 292 10.1038/s41586-020-2475-6
DeBerardinis R.J. Lum J.J. Hatzivassiliou G. Thompson C.B. The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation Cell Metab. 2008 7 11 20 10.1016/j.cmet.2007.10.002 18177721
Perera R.M. Bardeesy N. Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up Cancer Discov. 2015 5 1247 1261 10.1158/2159-8290.CD-15-0671
Sousa C.M. Kimmelman A.C. The Complex Landscape of Pancreatic Cancer Metabolism Carcinogenesis 2014 35 1441 1450 10.1093/carcin/bgu097 24743516
Shim H. Dolde C. Lewis B.C. Wu C.S. Dang G. Jungmann R.A. Dalla-Favera R. Dang C.V. C-Myc Transactivation of LDH-A: Implications for Tumor Metabolism and Growth Proc. Natl. Acad. Sci. USA 1997 94 6658 6663 10.1073/pnas.94.13.6658
Ying H. Kimmelman A.C. Lyssiotis C.A. Hua S. Chu G.C. Fletcher-Sananikone E. Locasale J.W. Son J. Zhang H. Coloff J.L. et al. Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism Cell 2012 149 656 670 10.1016/j.cell.2012.01.058
Knudsen E.S. Balaji U. Freinkman E. McCue P. Witkiewicz A.K. Unique Metabolic Features of Pancreatic Cancer Stroma: Relevance to the Tumor Compartment, Prognosis, and Invasive Potential Oncotarget 2016 7 78396 78411 10.18632/oncotarget.11893
Zhang D. Wang Y. Shi Z. Liu J. Sun P. Hou X. Zhang J. Zhao S. Zhou B.P. Mi J. Metabolic Reprogramming of Cancer-Associated Fibroblasts by IDH3α Downregulation Cell Rep. 2015 10 1335 1348 10.1016/j.celrep.2015.02.006 25732824
Pavlides S. Whitaker-Menezes D. Castello-Cros R. Flomenberg N. Witkiewicz A.K. Frank P.G. Casimiro M.C. Wang C. Fortina P. Addya S. et al. The Reverse Warburg Effect: Aerobic Glycolysis in Cancer Associated Fibroblasts and the Tumor Stroma Cell Cycle 2009 8 3984 4001 10.4161/cc.8.23.10238 19923890
Zhao H. Yang L. Baddour J. Achreja A. Bernard V. Moss T. Marini J.C. Tudawe T. Seviour E.G. San Lucas F.A. et al. Tumor Microenvironment Derived Exosomes Pleiotropically Modulate Cancer Cell Metabolism eLife 2016 5 e10250 10.7554/eLife.10250 26920219
Mullen A.R. Wheaton W.W. Jin E.S. Chen P.-H. Sullivan L.B. Cheng T. Yang Y. Linehan W.M. Chandel N.S. DeBerardinis R.J. Reductive Carboxylation Supports Growth in Tumour Cells with Defective Mitochondria Nature 2012 481 385 388 10.1038/nature10642
Wise D.R. Ward P.S. Shay J.E.S. Cross J.R. Gruber J.J. Sachdeva U.M. Platt J.M. DeMatteo R.G. Simon M.C. Thompson C.B. Hypoxia Promotes Isocitrate Dehydrogenase-Dependent Carboxylation of α-Ketoglutarate to Citrate to Support Cell Growth and Viability Proc. Natl. Acad. Sci. USA 2011 108 19611 19616 10.1073/pnas.1117773108
Metallo C.M. Gameiro P.A. Bell E.L. Mattaini K.R. Yang J. Hiller K. Jewell C.M. Johnson Z.R. Irvine D.J. Guarente L. et al. Reductive Glutamine Metabolism by IDH1 Mediates Lipogenesis under Hypoxia Nature 2012 481 380 384 10.1038/nature10602
Commisso C. Davidson S.M. Soydaner-Azeloglu R.G. Parker S.J. Kamphorst J.J. Hackett S. Grabocka E. Nofal M. Drebin J.A. Thompson C.B. et al. Macropinocytosis of Protein Is an Amino Acid Supply Route in Ras-Transformed Cells Nature 2013 497 633 637 10.1038/nature12138
Zhu Z. Achreja A. Meurs N. Animasahun O. Owen S. Mittal A. Parikh P. Lo T.-W. Franco-Barraza J. Shi J. et al. Tumour-Reprogrammed Stromal BCAT1 Fuels Branched-Chain Ketoacid Dependency in Stromal-Rich PDAC Tumours Nat. Metab. 2020 2 775 792 10.1038/s42255-020-0226-5
Sousa C.M. Biancur D.E. Wang X. Halbrook C.J. Sherman M.H. Zhang L. Kremer D. Hwang R.F. Witkiewicz A.K. Ying H. et al. Pancreatic Stellate Cells Support Tumour Metabolism through Autophagic Alanine Secretion Nature 2016 536 479 483 10.1038/nature19084
Auciello F.R. Bulusu V. Oon C. Tait-Mulder J. Berry M. Bhattacharyya S. Tumanov S. Allen-Petersen B.L. Link J. Kendsersky N.D. et al. A Stromal Lysolipid–Autotaxin Signaling Axis Promotes Pancreatic Tumor Progression Cancer Discov. 2019 9 617 627 10.1158/2159-8290.CD-18-1212
Almoguera C. Shibata D. Forrester K. Martin J. Arnheim N. Perucho M. Most Human Carcinomas of the Exocrine Pancreas Contain Mutant C-K-Ras Genes Cell 1988 53 549 554 10.1016/0092-8674(88)90571-5 2453289
Sherman M.H. Yu R.T. Tseng T.W. Sousa C.M. Liu S. Truitt M.L. He N. Ding N. Liddle C. Atkins A.R. et al. Stromal Cues Regulate the Pancreatic Cancer Epigenome and Metabolome Proc. Natl. Acad. Sci. USA 2017 114 1129 1134 10.1073/pnas.1620164114 28096419
Yan B. Jiang Z. Cheng L. Chen K. Zhou C. Sun L. Qian W. Li J. Cao J. Xu Q. et al. Paracrine HGF/c-MET Enhances the Stem Cell-like Potential and Glycolysis of Pancreatic Cancer Cells via Activation of YAP/HIF-1α Exp. Cell Res. 2018 371 63 71 10.1016/j.yexcr.2018.07.041 30056064
Tape C.J. Ling S. Dimitriadi M. McMahon K.M. Worboys J.D. Leong H.S. Norrie I.C. Miller C.J. Poulogiannis G. Lauffenburger D.A. et al. Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation Cell 2016 165 910 920 10.1016/j.cell.2016.03.029
Demircioglu F. Wang J. Candido J. Costa A.S.H. Casado P. de Luxan Delgado B. Reynolds L.E. Gomez-Escudero J. Newport E. Rajeeve V. et al. Cancer Associated Fibroblast FAK Regulates Malignant Cell Metabolism Nat. Commun. 2020 11 1290 10.1038/s41467-020-15104-3
Naba A. Clauser K.R. Hoersch S. Liu H. Carr S.A. Hynes R.O. The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices Mol. Cell Proteom. MCP 2012 11 M111.014647 10.1074/mcp.M111.014647
Tian C. Clauser K.R. Öhlund D. Rickelt S. Huang Y. Gupta M. Mani D.R. Carr S.A. Tuveson D.A. Hynes R.O. Proteomic Analyses of ECM during Pancreatic Ductal Adenocarcinoma Progression Reveal Different Contributions by Tumor and Stromal Cells Proc. Natl. Acad. Sci. USA 2019 116 19609 19618 10.1073/pnas.1908626116
Heldin C.-H. Rubin K. Pietras K. Östman A. High Interstitial Fluid Pressure—An Obstacle in Cancer Therapy Nat. Rev. Cancer 2004 4 806 813 10.1038/nrc1456
Koong A.C. Mehta V.K. Le Q.T. Fisher G.A. Terris D.J. Brown J.M. Bastidas A.J. Vierra M. Pancreatic Tumors Show High Levels of Hypoxia Int. J. Radiat. Oncol. 2000 48 919 922 10.1016/S0360-3016(00)00803-8
Winkler J. Abisoye-Ogunniyan A. Metcalf K.J. Werb Z. Concepts of Extracellular Matrix Remodelling in Tumour Progression and Metastasis Nat. Commun. 2020 11 5120 10.1038/s41467-020-18794-x
Ranniger K. Saldino R.M. Arteriographic Diagnosis of Pancreatic Lesions Radiology 1966 86 470 474 10.1148/86.3.470 5931771
Erkan M. Reiser-Erkan C. Michalski C.W. Kong B. Esposito I. Friess H. Kleeff J. The Impact of the Activated Stroma on Pancreatic Ductal Adenocarcinoma Biology and Therapy Resistance Curr. Mol. Med. 2012 12 288 303 10.2174/156652412799218921 22272725
Kisker O. Onizuka S. Banyard J. Komiyama T. Becker C.M. Achilles E.G. Barnes C.M. O’Reilly M.S. Folkman J. Pirie-Shepherd S.R. Generation of Multiple Angiogenesis Inhibitors by Human Pancreatic Cancer1 Cancer Res. 2001 61 7298 7304
Masamune A. Kikuta K. Watanabe T. Satoh K. Hirota M. Shimosegawa T. Hypoxia Stimulates Pancreatic Stellate Cells to Induce Fibrosis and Angiogenesis in Pancreatic Cancer Am. J. Physiol.-Gastrointest. Liver Physiol. 2008 295 G709 G717 10.1152/ajpgi.90356.2008
Erkan M. Reiser-Erkan C. Michalski C.W. Deucker S. Sauliunaite D. Streit S. Esposito I. Friess H. Kleeff J. Cancer-Stellate Cell Interactions Perpetuate the Hypoxia-Fibrosis Cycle in Pancreatic Ductal Adenocarcinoma Neoplasia 2009 11 497 508 10.1593/neo.81618
Spivak-Kroizman T.R. Hostetter G. Posner R. Aziz M. Hu C. Demeure M.J. Von Hoff D. Hingorani S.R. Palculict T.B. Izzo J. et al. Hypoxia Triggers Hedgehog-Mediated Tumor-Stromal Interactions in Pancreatic Cancer Cancer Res. 2013 73 3235 3247 10.1158/0008-5472.CAN-11-1433
Li X. Truty M.A. Kang Y. Chopin-Laly X. Zhang R. Roife D. Chatterjee D. Lin E. Thomas R.M. Wang H. et al. Extracellular Lumican Inhibits Pancreatic Cancer Cell Growth and Is Associated with Prolonged Survival after Surgery Clin. Cancer Res. 2014 20 6529 6540 10.1158/1078-0432.CCR-14-0970
Li X. Lee Y. Kang Y. Dai B. Perez M.R. Pratt M. Koay E.J. Kim M. Brekken R.A. Fleming J.B. Hypoxia-Induced Autophagy of Stellate Cells Inhibits Expression and Secretion of Lumican into Microenvironment of Pancreatic Ductal Adenocarcinoma Cell Death Differ. 2019 26 382 393 10.1038/s41418-018-0207-3
Chang Q. Jurisica I. Do T. Hedley D.W. Hypoxia Predicts Aggressive Growth and Spontaneous Metastasis Formation from Orthotopically Grown Primary Xenografts of Human Pancreatic Cancer Cancer Res. 2011 71 3110 3120 10.1158/0008-5472.CAN-10-4049
Daniel S.K. Sullivan K.M. Labadie K.P. Pillarisetty V.G. Hypoxia as a Barrier to Immunotherapy in Pancreatic Adenocarcinoma Clin. Transl. Med. 2019 8 10 10.1186/s40169-019-0226-9
Kaelin W.G. Ratcliffe P.J. Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway Mol. Cell 2008 30 393 402 10.1016/j.molcel.2008.04.009 18498744
Ye L.-Y. Zhang Q. Bai X.-L. Pankaj P. Hu Q.-D. Liang T.-B. Hypoxia-Inducible Factor 1α Expression and Its Clinical Significance in Pancreatic Cancer: A Meta-Analysis Pancreatol. Off. J. Int. Assoc. Pancreatol. IAP Al 2014 14 391 397 10.1016/j.pan.2014.06.008 25278309
Erkan M. Kurtoglu M. Kleeff J. The Role of Hypoxia in Pancreatic Cancer: A Potential Therapeutic Target? Expert Rev. Gastroenterol. Hepatol. 2016 10 301 316 10.1586/17474124.2016.1117386 26560854
Chandel N.S. McClintock D.S. Feliciano C.E. Wood T.M. Melendez J.A. Rodriguez A.M. Schumacker P.T. Reactive Oxygen Species Generated at Mitochondrial Complex III Stabilize Hypoxia-Inducible Factor-1alpha during Hypoxia: A Mechanism of O2 Sensing J. Biol. Chem. 2000 275 25130 25138 10.1074/jbc.M001914200 10833514
Guillaumond F. Leca J. Olivares O. Lavaut M.-N. Vidal N. Berthezène P. Dusetti N.J. Loncle C. Calvo E. Turrini O. et al. Strengthened Glycolysis under Hypoxia Supports Tumor Symbiosis and Hexosamine Biosynthesis in Pancreatic Adenocarcinoma Proc. Natl. Acad. Sci. USA 2013 110 3919 3924 10.1073/pnas.1219555110
He G. Jiang Y. Zhang B. Wu G. The Effect of HIF-1alpha on Glucose Metabolism, Growth and Apoptosis of Pancreatic Cancerous Cells Asia Pac. J. Clin. Nutr. 2014 23 174 180 10.3316/ielapa.136067772733242
Zhu H. Wang D. Zhang L. Xie X. Wu Y. Liu Y. Shao G. Su Z. Upregulation of Autophagy by Hypoxia-Inducible Factor-1α Promotes EMT and Metastatic Ability of CD133+ Pancreatic Cancer Stem-like Cells during Intermittent Hypoxia Oncol. Rep. 2014 32 935 942 10.3892/or.2014.3298
He X. Wang J. Wei W. Shi M. Xin B. Zhang T. Shen X. Hypoxia Regulates ABCG2 Activity through the Activivation of ERK1/2/HIF-1α and Contributes to Chemoresistance in Pancreatic Cancer Cells Cancer Biol. Ther. 2016 17 188 198 10.1080/15384047.2016.1139228
Olivares O. Mayers J.R. Gouirand V. Torrence M.E. Gicquel T. Borge L. Lac S. Roques J. Lavaut M.-N. Berthezène P. et al. Collagen-Derived Proline Promotes Pancreatic Ductal Adenocarcinoma Cell Survival under Nutrient Limited Conditions Nat. Commun. 2017 8 16031 10.1038/ncomms16031
Corbet C. Feron O. Tumour Acidosis: From the Passenger to the Driver’s Seat Nat. Rev. Cancer 2017 17 577 593 10.1038/nrc.2017.77
Halestrap A.P. Price N.T. The Proton-Linked Monocarboxylate Transporter (MCT) Family: Structure, Function and Regulation Biochem. J. 1999 343 281 299 10.1042/bj3430281 10510291
Li X. Zhu H. Sun W. Yang X. Nie Q. Fang X. Role of Glutamine and Its Metabolite Ammonia in Crosstalk of Cancer-Associated Fibroblasts and Cancer Cells Cancer Cell Int. 2021 21 479 10.1186/s12935-021-02121-5 34503536
Supuran C.T. Carbonic Anhydrases: Novel Therapeutic Applications for Inhibitors and Activators Nat. Rev. Drug Discov. 2008 7 168 181 10.1038/nrd2467 18167490
Strapcova S. Takacova M. Csaderova L. Martinelli P. Lukacikova L. Gal V. Kopacek J. Svastova E. Clinical and Pre-Clinical Evidence of Carbonic Anhydrase IX in Pancreatic Cancer and Its High Expression in Pre-Cancerous Lesions Cancers 2020 12 2005 10.3390/cancers12082005
Svastová E. Hulíková A. Rafajová M. Zat’ovicová M. Gibadulinová A. Casini A. Cecchi A. Scozzafava A. Supuran C.T. Pastorek J. et al. Hypoxia Activates the Capacity of Tumor-Associated Carbonic Anhydrase IX to Acidify Extracellular PH FEBS Lett. 2004 577 439 445 10.1016/j.febslet.2004.10.043
Chen S. Ning B. Song J. Yang Z. Zhou L. Chen Z. Mao L. Liu H. Wang Q. He S. et al. Enhanced Pentose Phosphate Pathway Activity Promotes Pancreatic Ductal Adenocarcinoma Progression via Activating YAP/MMP1 Axis under Chronic Acidosis Int. J. Biol. Sci. 2022 18 2304 2316 10.7150/ijbs.69526
Dovmark T.H. Saccomano M. Hulikova A. Alves F. Swietach P. Connexin-43 Channels Are a Pathway for Discharging Lactate from Glycolytic Pancreatic Ductal Adenocarcinoma Cells Oncogene 2017 36 4538 4550 10.1038/onc.2017.71
Zeng S. Pöttler M. Lan B. Grützmann R. Pilarsky C. Yang H. Chemoresistance in Pancreatic Cancer Int. J. Mol. Sci. 2019 20 4504 10.3390/ijms20184504
Neesse A. Bauer C.A. Öhlund D. Lauth M. Buchholz M. Michl P. Tuveson D.A. Gress T.M. Stromal Biology and Therapy in Pancreatic Cancer: Ready for Clinical Translation? Gut 2019 68 159 171 10.1136/gutjnl-2018-316451
Vaish U. Jain T. Are A.C. Dudeja V. Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma: An Update on Heterogeneity and Therapeutic Targeting Int. J. Mol. Sci. 2021 22 13408 10.3390/ijms222413408
Zhang T. Ren Y. Yang P. Wang J. Zhou H. Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Cell Death Dis. 2022 13 13408 10.1038/s41419-022-05351-1 36284087
Chauhan V.P. Martin J.D. Liu H. Lacorre D.A. Jain S.R. Kozin S.V. Stylianopoulos T. Mousa A.S. Han X. Adstamongkonkul P. et al. Angiotensin Inhibition Enhances Drug Delivery and Potentiates Chemotherapy by Decompressing Tumour Blood Vessels Nat. Commun. 2013 4 2516 10.1038/ncomms3516 24084631
Provenzano P.P. Cuevas C. Chang A.E. Goel V.K. Von Hoff D.D. Hingorani S.R. Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma Cancer Cell 2012 21 418 429 10.1016/j.ccr.2012.01.007 22439937
Van Cutsem E. Tempero M.A. Sigal D. Oh D.-Y. Fazio N. Macarulla T. Hitre E. Hammel P. Hendifar A.E. Bates S.E. et al. Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 2020 38 3185 3194 10.1200/JCO.20.00590 32706635
Murphy J.E. Wo J.Y. Ryan D.P. Clark J.W. Jiang W. Yeap B.Y. Drapek L.C. Ly L. Baglini C.V. Blaszkowsky L.S. et al. Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical Trial JAMA Oncol. 2019 5 1020 1027 10.1001/jamaoncol.2019.0892
Rauta P.R. Mackeyev Y. Sanders K. Kim J.B.K. Gonzalez V.V. Zahra Y. Shohayeb M.A. Abousaida B. Vijay G.V. Tezcan O. et al. Pancreatic Tumor Microenvironmental Acidosis and Hypoxia Transform Gold Nanorods into Cell-Penetrant Particles for Potent Radiosensitization Sci. Adv. 2022 8 eabm9729 10.1126/sciadv.abm9729
Melisi D. Garcia-Carbonero R. Macarulla T. Pezet D. Deplanque G. Fuchs M. Trojan J. Oettle H. Kozloff M. Cleverly A. et al. Galunisertib plus Gemcitabine vs. Gemcitabine for First-Line Treatment of Patients with Unresectable Pancreatic Cancer Br. J. Cancer 2018 119 1208 1214 10.1038/s41416-018-0246-z
Olive K.P. Jacobetz M.A. Davidson C.J. Gopinathan A. McIntyre D. Honess D. Madhu B. Goldgraben M.A. Caldwell M.E. Allard D. et al. Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer Science 2009 324 1457 1461 10.1126/science.1171362
Richards D.A. Stephenson J. Wolpin B.M. Becerra C. Hamm J.T. Messersmith W.A. Devens S. Cushing J. Schmalbach T. Fuchs C.S. A Phase Ib Trial of IPI-926, a Hedgehog Pathway Inhibitor, plus Gemcitabine in Patients with Metastatic Pancreatic Cancer J. Clin. Oncol. 2012 30 213 10.1200/jco.2012.30.4_suppl.213
Kim E.J. Sahai V. Abel E.V. Griffith K.A. Greenson J.K. Takebe N. Khan G.N. Blau J.L. Craig R. Balis U.G. et al. Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma Clin. Cancer Res. 2014 20 5937 5945 10.1158/1078-0432.CCR-14-1269
Özdemir B.C. Pentcheva-Hoang T. Carstens J.L. Zheng X. Wu C.-C. Simpson T.R. Laklai H. Sugimoto H. Kahlert C. Novitskiy S.V. et al. Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival Cancer Cell 2014 25 719 734 10.1016/j.ccr.2014.04.005 24856586
Rhim A.D. Oberstein P.E. Thomas D.H. Mirek E.T. Palermo C.F. Sastra S.A. Dekleva E.N. Saunders T. Becerra C.P. Tattersall I.W. et al. Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma Cancer Cell 2014 25 735 747 10.1016/j.ccr.2014.04.021 24856585
